Oncology PracticeWhy Lung Cancer Screening Is Not for EveryoneApril 19, 2024Preventive CareLung CancerOncologyPulmonologyPatient & Survivor Care
Oncology PracticeAdding ACEI to Chemotherapy Does Not Prevent CardiotoxicityApril 19, 2024Patient & Survivor CareBreast CancerLymphoma & Plasma Cell DisordersPreventive CareMixed TopicsNon-Hodgkin LymphomaACC Conference Coverage
Oncology PracticeWhat’s Driving the Higher Breast Cancer Death Rate in Black Women?April 18, 2024Breast CancerBusiness of MedicineDiversity in MedicinePreventive CareMetastatic Breast CancerPractice ManagementPatient & Survivor CareOncologyWomen's Health
Hematology NewsTiming Is Everything: CAR T for Follicular LymphomaApril 18, 2024Non-Hodgkin LymphomaCellular Therapy
Oncology PracticeMicrobial Signature of KRAS-Mutated Colorectal Cancer IdentifiedApril 18, 2024Gastrointestinal CancerGastroenterologyPatient & Survivor Care
Oncology PracticeCertain Women May Face Higher Risk for Second Breast CancerApril 17, 2024Breast CancerMetastatic Breast CancerPatient & Survivor CareOncologyWomen's Health
Oncology PracticeMost Targeted Cancer Drugs Lack Substantial Clinical BenefitApril 17, 2024Practice ManagementBreast CancerCNS/Brain CancerDLBCLFollicular LymphomaGastrointestinal CancerGenitourinary CancerGynecologic CancerGene TherapyHead & Neck/Thyroid CancersImmunotherapyLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMetastatic Breast CancerMelanomaNeuro-oncologyNonmelanoma Skin CancerPatient & Survivor CarePreventive CareSarcoma & GISTRenal Cell CarcinomaPediatricsMixed TopicsBusiness of MedicineALLAggressive LymphomasAMLB Cell LymphomaCellular TherapyCLLCMLHodgkin LymphomaIndolent LymphomaMantle Cell LymphomaNon-Hodgkin LymphomaT Cell LymphomasMultiple Myeloma
Hematology NewsPhysicians Own Less Than Half of US Practices; Federal Agencies Want Outside InputApril 17, 2024Business of MedicinePractice Management
Hormone + Radiation Therapy Better Than Either Treatment in Older Men With Early HR+ BCApril 17, 2024Breast Cancer
Impact of Adjuvant Ovarian Function Suppression on Recurrence Risk in Premenopausal HR+ Breast CancerApril 17, 2024Breast Cancer
Adjuvant Chemotherapy May be Omitted in Older Women Aged 80 Years or Older With HR+/HER2- BCApril 17, 2024Breast Cancer
Antibiotic Exposure During Immunotherapy Increases Disease Burden in HER2− Early BC April 17, 2024Breast Cancer
Breast Cancer Radiation Therapy Raises Risk for Nonkeratinocyte Skin CancerApril 17, 2024Breast Cancer
MRI-Based Strategy Can Limit Neoadjuvant Chemotherapy Duration in HR−/HER2+ BCApril 17, 2024Breast Cancer
Novel Treatment Sequence Speeds Up Breast Reconstruction Procedures in Patients With Breast CancerApril 17, 2024Breast Cancer